Showing results (471-480 of 634) with videos related to

Sort By:
Pageof 64
Japanese Journal of Clinical Oncology|May 25, 2010
Sorafenib for recurrent hepatocellular carcinoma after liver transplantationDok Hyun Yoon, Baek-Yeol Ryoo, Min-Hee Ryu, et al.
Oncology Reports|November 3, 2010
Effects of the HDAC inhibitor CG2 in combination with irinotecan, 5-fluorouracil, or oxaliplatin on HCT116 colon cancer cells and xenograftsYoung-Soon Na, Seung-Mi Kim, Kyung-Ah Jung, et al.
Clinical Colorectal Cancer|February 23, 2017
HER2 Amplification and Cetuximab Efficacy in Patients With Metastatic Colorectal Cancer Harboring Wild-type RAS and BRAFJae Ho Jeong, Jihun Kim, Yong Sang Hong, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2017
Local Control Outcomes Using Stereotactic Body Radiation Therapy for Liver Metastases From Colorectal CancerJi Hyeon Joo, Jin-Hong Park, Jin Cheon Kim, et al.
Nucleic Acid Therapeutics|August 9, 2016
Disposition and Pharmacokinetics of a GalNAc3-Conjugated Antisense Oligonucleotide Targeting Human Lipoprotein (a) in MonkeysRosie Z Yu, Rudy Gunawan, Noah Post, et al.
Investigational New Drugs|June 28, 2011
Biweekly cetuximab plus irinotecan as second-line chemotherapy for patients with irinotecan-refractory and KRAS wild-type metastatic colorectal cancer according to epidermal growth factor receptor expression statusMyoung Joo Kang, Yong Sang Hong, Kyu-pyo Kim, et al.
The American Journal of the Medical Sciences|September 21, 2013
The MEK1/2 inhibitor AS703026 circumvents resistance to the BRAF inhibitor PLX4032 in human malignant melanoma cellsSeong Joon Park, Seung-Woo Hong, Jai-Hee Moon, et al.
Clinical Colorectal Cancer|November 23, 2020
Effectiveness of Combining Bevacizumab With First-Line Chemotherapy Regimens for Metastatic Colorectal Cancer in Real-World PracticeYeong Hak Bang, Yong Sang Hong, Ji Sung Lee, et al.
Radiation Oncology Journal|October 13, 2016
Preoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancerYoung Seob Shin, Yong Sik Yoon, Seok-Byung Lim, et al.
American Journal of Clinical Oncology|August 8, 2012
Randomized phase II study of capecitabine with or without oxaliplatin as first-line treatment for elderly or fragile patients with metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study Group CO06-01Yong Sang Hong, Kyung Hae Jung, Hwa Jung Kim, et al.
Pageof 64